Prolocor

Let's scratch the surface.

In the United States, atherosclerotic cardiovascular disease is a leading cause of death and disability for men, women, and people of most racial and ethnic groups.

let's dig deeper

There is a real unmet need.

Currently, there is no precise diagnostic tool that can effectively guide individualized therapy for patients with cardiovascular disease.

learn more

A big problem set us on an even bigger mission.

Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.

learn how we plan to fulfill it

Learn how we plan to help cardiovascular patients.

See how our technology will empower physicians.

Meet the future of precision diagnostics.

An innovative diagnostic test that is being developed to help doctors make more informed treatment decisions.

discover our test

Prolocor Announces the Publication of Two Important New Analyses from a Recently Completed Clinical Study

May 20, 2026

Prolocor Announces Results of NIH-funded Study Demonstrating That Platelet FcγRIIa Identifies Cancer Patients at Increased Risk of Death and Thrombotic Events

March 2, 2026

A novel diagnostic test to quantify FcyRIIa on the surface of platelets.

Let's scratch the surface.

There is a real unmet need.

A big problem set us on an even bigger mission.

Meet the future of precision diagnostics.

Prolocor Announces the Publication of Two Important New Analyses from a Recently Completed Clinical Study

Prolocor Announces Results of NIH-funded Study Demonstrating That Platelet FcγRIIa Identifies Cancer Patients at Increased Risk of Death and Thrombotic Events

Prolocor^® Research Named a “Top 10 Article of 2025” by the Journal of Invasive Cardiology

Let's scratch the surface.

There is a real unmet need.

A big problem set us on an even bigger mission.

Meet the future of precision diagnostics.

Prolocor Announces the Publication of Two Important New Analyses from a Recently Completed Clinical Study

Prolocor Announces Results of NIH-funded Study Demonstrating That Platelet FcγRIIa Identifies Cancer Patients at Increased Risk of Death and Thrombotic Events

Prolocor® Research Named a “Top 10 Article of 2025” by the Journal of Invasive Cardiology

Prolocor^® Research Named a “Top 10 Article of 2025” by the Journal of Invasive Cardiology